CHD vs PPCB · P/E 32, rev $6.11B vs P/E 0.0, $3.9M cap
Church & Dwight Company Inc (CHD) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
PPCB does not have a complete income-statement cache yet.
CHD currently screens at market cap $23.08B and trailing P/E 32.0. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the CHD and PPCB stock pages for the full models.
Not investment advice.